DALS NASDAQ
DA32 Life Science Tech Acquisition Corp.
1W: +0.3%
1M: +0.6%
3M: +1.5%
1Y: +6.0%
$10.30
Last traded 2023-07-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$264.2M
52W Range9.68-11.22
Volume2,248
Avg Volume29,221
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSteven Kafka
SectorFinancial Services
IndustryShell Companies
IPO Date2021-07-28
345 Park Avenue South
New York City, NY 10010
US
New York City, NY 10010
US
212-551-1600
About DA32 Life Science Tech Acquisition Corp.
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Section 32 Fund 3, L | D-Return | 701,250 | — | 2021-08-05 |
| Section 32 Fund 3, L | D-Return | 30,000 | — | 2021-08-05 |
| DEERFIELD MANAGEMENT | D-Return | 701,250 | — | 2021-08-05 |
| Wolfe Chris | D-Return | 18,750 | — | 2021-08-05 |
| CRANDELL KEITH | D-Return | 701,250 | — | 2021-08-05 |